Renaissance Capital logo

ACXP News

US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week

DOCS

16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate (SSR). Doximity (DOCS) priced above the range to raise...read more

Micro-cap antibiotic biotech Acurx Pharmaceuticals prices IPO at $6 midpoint

ACXP

Acurx Pharmaceuticals, a phase 2 biotech developing antibiotics for antibiotic-resistant pathogens, raised $15 million by offering 2.5 million shares at $6, within the range of $5 to $7. At pricing, the company commands a fully diluted market value of $62 million. Acurx Pharmaceuticals is developing a new class of antibiotics for infections caused by bacteria listed as priority...read more

US IPO Week Ahead: Billion-dollar deals come to market in a 17 IPO week

YMM

Updated Monday, 6/21/21. 17 IPOs are scheduled to raise $6.3 billion in the week ahead, led by two billion-dollar deals. Chinese freight platform Full Truck Alliance (YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights,...read more

Micro-cap antibiotic biotech Acurx Pharmaceuticals files and sets terms for a $15 million IPO

ACXP

Acurx Pharmaceuticals, a Phase 2 biotech developing antibiotics for antibiotic-resistant pathogens, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.  The company plans to raise $15 million by offering 2.5 million shares at a price range of $5 to $7. At the midpoint of the proposed range, Acurx Pharmaceutical would command a market...read more

Archived Headlines